Journal article
PAXIS: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Phase 2 Study (Part 1) Followed by an Open-Label Period (Part 2) to Assess the Efficacy and Safety of Pacritinib in Patients with VEXAS Syndrome
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 1.0MB, Terms of use)
-
- Publisher copy:
- 10.3390/jcm15041426
Authors
- Publisher:
- MDPI
- Journal:
- Journal of Clinical Medicine More from this journal
- Volume:
- 15
- Issue:
- 4
- Publication date:
- 2026-02-01
- Acceptance date:
- 2026-02-09
- DOI:
- EISSN:
-
2077-0383
- ISSN:
-
2077-0383
- Language:
-
English
- Keywords:
- Pubs id:
-
2383414
- Local pid:
-
pubs:2383414
- Source identifiers:
-
3829640
- Deposit date:
-
2026-03-07
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2026
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record